BESTHOF ROBERT

PrivateCIK: 1864650
Location

WILMINGTON, DE

BESTHOF ROBERT (Chief Comm. & Patient Officer) sold 62.8% of their position (40K shares) of NRX PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $470.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderBESTHOF ROBERTCIK 1864650
IssuerNRX PHARMACEUTICALS, INC.CIK 1719406
Officer· Chief Comm. & Patient Officer
Since May 2021
-40K
Net shares
Net seller
$470.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
100K acquired · 140K disposed
Non-Derivative Transactions2

Common Stock

Direct
M · Option Exercise

Shares

+63.71K

Price / share

$0.20

Trade value

$12.74K

% of position

New position
8/16/2021
0.0063.71K

Common Stock

Direct
S · Sale

Shares

40K

Price / share

$11.76

Trade value

$470.40K

% of position

62.8%
9/15/2021
63.71K23.71K
Total

Net shares

+23.71K

Net value

-$457.66K

Derivative Transactions2

Employee Stock Option (Right to buy)

Direct
C · Conversion
Converts to

Common Stock

100K shares

Shares

100K

Strike price

0.20

Held after

247.20K

Exercisable

8/16/2021

Restricted Stock Units

Direct
A · Award
Converts to

Common Stock

36.29K shares

Shares

+36.29K

Strike price

Held after

36.29K

Exercisable

8/16/2021
BESTHOF ROBERT — Insider Transaction (Form 4) Filed Nov 2, 2021 | Finecho